These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26932231)

  • 1. Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development.
    Schiechl G; Hermann FJ; Rodriguez Gomez M; Kutzi S; Schmidbauer K; Talke Y; Neumayer S; Goebel N; Renner K; Brühl H; Karasuyama H; Obata-Ninomiya K; Utpatel K; Evert M; Hirt SW; Geissler EK; Fichtner-Feigl S; Mack M
    Am J Transplant; 2016 Sep; 16(9):2574-88. PubMed ID: 26932231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils.
    Balam S; Schiechl-Brachner G; Buchtler S; Halbritter D; Schmidbauer K; Talke Y; Neumayer S; Salewski JN; Winter F; Karasuyama H; Yamanishi Y; Renner K; Geissler EK; Mack M
    J Immunol; 2019 Jun; 202(12):3514-3523. PubMed ID: 31068389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts.
    Balam S; Buchtler S; Winter F; Schmidbauer K; Neumayer S; Talke Y; Renner K; Geissler EK; Mack M
    Front Immunol; 2021; 12():816509. PubMed ID: 35126373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.
    Booth AJ; Wood SC; Cornett AM; Dreffs AA; Lu G; Muro AF; White ES; Bishop DK
    J Pathol; 2012 Mar; 226(4):609-18. PubMed ID: 21960174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.
    Zhang ZX; Huang X; Jiang J; Lian D; Min WP; Liu W; Haig A; Jevnikar AM
    Transplantation; 2014 Nov; 98(10):1029-39. PubMed ID: 25286056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
    Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
    Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.
    Lin CM; Gill RG; Mehrad B
    Am J Transplant; 2021 Nov; 21(11):3550-3560. PubMed ID: 34014614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.
    Le Moine A; Flamand V; Demoor FX; Noël JC; Surquin M; Kiss R; Nahori MA; Pretolani M; Goldman M; Abramowicz D
    J Clin Invest; 1999 Jun; 103(12):1659-67. PubMed ID: 10377172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection.
    Khattar M; Baum CE; Schroder P; Breidenbach JD; Haller ST; Chen W; Stepkowski S
    PLoS One; 2019; 14(11):e0225624. PubMed ID: 31756235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose IL-2 prevents murine chronic cardiac allograft rejection: Role for IL-2-induced T regulatory cells and exosomes with PD-L1 and CD73.
    Ravichandran R; Itabashi Y; Fleming T; Bansal S; Bowen S; Poulson C; Bharat A; Bremner R; Smith M; Mohanakumar T
    Am J Transplant; 2022 Sep; 22(9):2180-2194. PubMed ID: 35603986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.
    Diaz JA; Booth AJ; Lu G; Wood SC; Pinsky DJ; Bishop DK
    Am J Transplant; 2009 Aug; 9(8):1773-83. PubMed ID: 19538487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process.
    Piccotti JR; Li K; Chan SY; Eichwald EJ; Bishop DK
    Transplantation; 1999 Jun; 67(12):1548-55. PubMed ID: 10401761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy
    Zhang Z; Zhang N; Shi J; Dai C; Wu S; Jiao M; Tang X; Liu Y; Li X; Xu Y; Tan Z; Gong F; Zheng F
    Front Immunol; 2021; 12():657803. PubMed ID: 33815420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.
    Shi X; Zhang M; Liu F; Wang Z; Zhang L; Cheng H; Zhang S; Fei T; Guo M; Bian J; Wang Q; Ding G
    Int J Clin Exp Pathol; 2014; 7(2):509-20. PubMed ID: 24551271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling.
    Zou H; Ming B; Li J; Xiao Y; Lai L; Gao M; Xu Y; Tan Z; Gong F; Zheng F
    Front Immunol; 2021; 12():641973. PubMed ID: 33777037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
    Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
    Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.